Hint mode is switched on Switch off

Abivax, American depositary receipt (ADR)
ABVX, US00370M1036

FIND, SAVE & TRACK INVESTMENTS WITH CBONDS WATCHLIST

With Cbonds Watchlist you can always stay updated on your investments to make conscious decisions!

Watchlist
You need to request access
Add a stock to WL
Choose all Reset all
Abivax, сountry — France
No trading data
Data display in a chart | table
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
No data
from
to
ADD-IN
Cbonds add-in API
bond data api
Authorization required
You need to request access
More than 2,500 records have been found, please specify your request
No data for the selected period
Welcome to Cbonds
New to Cbonds? · Take a 90-second tour of the platform.

Discover what you can do with Cbonds

Everything you need for fixed income research and monitoring.

  • 00:23 Coverage
  • 00:40 Bond screener
  • 00:54 Parameters
  • 01:10 Watchlist, Mobile app
  • 01:15 Excel Add-in
Unlock data Watch full tour

Latest quotes

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Get access to the largest financial database

Representative of the company 7 days FREE trial

Professional access to the data

Private investor

Individual access

Analysts forecasts

  • median ***
  • average ***
  • min ***
  • max ***

Issuer

Profile
Abivax SA, a biotechnology company, develops, markets, and commercializes anti-viral therapies and therapeutic vaccines for the treatment of infectious diseases in Asia and Latin America.
  • Issuer
  • Full borrower / issuer name
    Abivax SA
  • Industry
    Pharmaceutical Preparation and Biotechnology

Placement data

  • Placement type
    IPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    ABVX
  • Placement
    20.10.2023
  • Lock up period
    180
  • Number of papers
    18,699,460
  • Volume of raised funds
    216.91 mln USD
  • Placement share
    29.74%
  • Final placement price
    11.6 USD
  • Price change since placement date
    -100%
  • By capitalization
    729.33 mln USD

IFRS/US GAAP reports

2025
IV q eng
2024
IV q eng
2023
IV q eng
Show more Hide

Related Stock indices

Indicators

News

02/06/2026 Abivax (NASDAQ:ABVX) Stock Plunges Amid Cancer Concerns, Jefferies Sets Bearish Price Target
24/07/2025 Significant Gains in the Stock Market: A Closer Look at Top Performers
All organization news

Other stocks and deposit receipts

Holders

Industry Leaders

Registration is required to get access.